Done sou Salè H1B

Akèy › Vil › Massachusetts › Cambridge

Pwonse H-1B nan Cambridge, MA

Anplwayè yo te depoze 8,991 aplikasyon kondisyon travay pou travay nan Cambridge, MA pandan ane fiskal 2023–2026. Salè baz medyàn ofri: $122,574.

Demann (LCA)8,991
Salè medyan ofri$122,574
Mwatye salè yo$90,000–$155,000
10yèm–90yèm pousantaj$71,750–$186,971

Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →

Pi gwo pwonse yo

AnplwayèLCASalè medyan
Massachusetts Institute of Technology793$78,000
Harvard University466$74,880
Google LLC404$164,000
Takeda Development Center Americas, Inc.321$155,000
The Broad Institute, Inc.303$94,750
Novartis Institutes for BioMedical Research, Inc.286$93,891
Biogen Inc.238$121,555
HubSpot, Inc.233$157,600
Akamai Technologies, Inc.224$147,143
Microsoft Corporation189$156,450
ModernaTX, Inc.155$125,500
Amgen Inc.128$123,600
Amazon.com Services LLC127$153,800
Sanofi US Services Inc.122$123,875
Intellia Therapeutics122$127,900
Meta Platforms, Inc104$189,140
Alnylam US, Inc.103$140,795
Philips North America LLC87$123,906
Apple Inc.83$148,054
Zifo Technologies, Inc83$87,447
Takeda Pharmaceuticals USA, Inc.69$184,812
IBM Corporation67$203,010
Audible, Inc.66$153,353
Genzyme Corporation66$140,625
Moderna Services, Inc.64$144,997
CarGurus, Inc.61$166,900
Whitehead Institute for Biomedical Research55$73,440
Ernst & Young U.S. LLP52$121,975
General Hospital Corporation51$71,406
InterSystems Corporation50$120,000
Cambridge Mobile Telematics, Inc.47$137,946
Bristol-Myers Squibb Company43$151,979
KAYAK Software Corporation39$122,750
Beam Therapeutics, Inc.36$120,000
Cambridge Public Health Commission35$83,533
Boston Dynamics AI Institute, LLC35$180,000
BioNTech US Inc.33$124,000
Pegasystems Inc.33$145,500
Everquote, Inc.33$90,230
Pfizer Inc.32$116,116
AbbVie Bioresearch Center Inc.31$129,000
Cognizant Technology Solutions US Corp31$116,355
Editas Medicine, Inc.31$110,000
Prime Medicine, Inc.29$113,850
Brigham and Women's Hospital29$72,375
Blueprint Medicines Corporation28$154,832
Novartis Pharmaceuticals Corporation26$118,966
Reed Hilderbrand LLC26$65,598
Lila Sciences, Inc.26$115,000
Smithsonian Astrophysical Observatory25$104,658
Sarepta Therapeutics, Inc.24$155,000
Howard Hughes Medical Institute24$79,050
Wave Life Sciences USA, Inc.24$115,700
Flagship Pioneering, Inc.24$160,000
Im Pro Makeup Ny LP24$115,000
Fujitsu North America, Inc.23$116,242
Regeneron Pharmaceuticals, Inc.23$146,016
Eli Lilly and Company22$131,500
KBR Wyle Services LLC22$137,289
Accenture LLP20$135,700

Oksipasyon

MetiyèLCASalè medyan
Software Developers1,625$154,606
Molecular and Cellular Biologists1,367$100,000
Biochemists and Biophysicists636$96,242
Medical Scientists, Except Epidemiologists506$113,470
Data Scientists498$137,946
Computer Systems Engineers/Architects269$135,000
Computer and Information Research Scientists232$168,000
Statisticians193$137,966
Chemists174$116,718
Bioengineers and Biomedical Engineers161$116,250
Operations Research Analysts155$118,000
Physicists131$74,590
Computer and Information Systems Managers121$195,228
Industrial Engineers114$102,669
Mechatronics Engineers105$149,000
Regulatory Affairs Managers99$169,288
Market Research Analysts and Marketing Specialists93$93,600
Chemical Engineers91$101,750
Computer Systems Analysts82$119,496
Software Quality Assurance Analysts and Testers70$121,020
Natural Sciences Managers69$212,000
Mechanical Engineers, R&D64$75,000
Financial and Investment Analysts62$100,222
Regulatory Affairs Specialists61$123,956
Biological Technicians57$75,000
Mechanical Engineers57$103,500
Management Analysts56$148,907
Accountants and Auditors54$90,000
Project Management Specialists51$112,944
Foreign Language and Literature Teachers, Postsecondary50$74,000

Tit travay

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).